Search Within

Zeynep Cagla Tarcan

Formats
  1. Meeting Abstract (14)
  2. Journal Article (5)
  3. Editorial (1)
  4. Miscellaneous (1)
  5. Review (1)
Groups
  1. Center for Pancreatic Cancer Research (20)
  2. Department of Pathology and Laboratory Medicine (20)
  3. Department of Medicine (5)
  4. Gastrointestinal Oncology Service (5)
  5. Solid Tumor Oncology Division (5)
  6. CTCR Scholars (3)

More Groups

People
  1. Olca Basturk (20)
  2. Anupriya Singhal (2)
  3. Eileen O'Reilly (2)
  4. Kerem Ozcan (2)
  5. Nitya Raj (2)
  6. Wungki Park (2)

More People

Years
  1. 2025 (7)
  2. 2024 (15)
Publications
  1. Laboratory Investigation (13)
  2. Annals of Surgical Oncology (4)
  3. Modern Pathology (2)
  4. American Journal of Surgical Pathology (1)
  5. Cancer Discovery (1)
  6. Journal of Clinical Oncology (1)
Publishers
  1. Nature Publishing Group (13)
  2. Springer (4)
  3. Nature Research (2)
  4. American Association for Cancer Research (1)
  5. American Society of Clinical Oncology (1)
  6. Lippincott Williams & Wilkins (1)

Results (22)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Applicability of artificial intelligence (AI) in infiltration-based grading of pancreatic neuroendocrine tumors
    Meeting Abstract

    Esmer, R.; Eren, O. C.; Koc, S.; Kasapoglu, Ü; Cesur, B.; Saka, B.; Tarcan, Z.; Basturk, O.; Gunduz-Demir, C.; Volkan Adsay, N.
    Laboratory Investigation (2024)

    Fulltext@MSK | Save
  • ARID1A-associated pancreatic carcinoma is metaplastic type with mucoepidermoid features and basal like immunophenotype: Delineation of the first genetic-phenotypic correlated variant of pancreas cancer
    Meeting Abstract

    Esmer, R.; Tarcan, Z.; Mericoz, M. A.; Saka, B.; Luchini, C.; Scarpa, A.; Gurses, B.; Bilge, O.; Volkan Adsay, N.
    Laboratory Investigation (2024)

    Fulltext@MSK | Save
  • Validation of the recently proposed sub-grading of G2 pancreatic neuroendocrine tumors as G2a (Ki67 index 3% - <10%) versus G2b (10% - 20%)
    Meeting Abstract

    Eren, O. C.; Tarcan, Z.; Esmer, R.; Luchini, C.; Raj, N.; Scarpa, A.; Basturk, O.; Volkan Adsay, N.
    Laboratory Investigation (2024)

    Fulltext@MSK | Save
  • Molecular profiling supports the recognition of metaplastic carcinoma as a new and distinct category in pancreatic cancer
    Meeting Abstract

    Esmer, R.; Mericoz, M. A.; Cengiz, D.; Saka, B.; Armutlu, A.; Bagci, P.; Pehlivanoglu, B.; Bozkurtlar, E.; Reid, M.; Alper, E.; more...
    Laboratory Investigation (2024)

    Fulltext@MSK | Save
  • Differences in Ki67 labeling index between primary and synchronous metastasis of pancreatic neuroendocrine tumors (PanNETs): Implications on daily practice
    Meeting Abstract

    Eren, O. C.; Esmer, R.; Adsay, D.; Bagci, P.; Tarcan, Z.; Basturk, O.; Saka, B.
    Laboratory Investigation (2024)

    Fulltext@MSK | Save
  • A proposal for a morphologic sub-classification of small duct-type intrahepatic cholangiocarcinomas with molecular correlation
    Meeting Abstract

    Armutlu, A.; Esmer, R.; Tarcan, Z.; Saka, B.; Balci, S.; Baygül, A.; Mericoz, M. A.; Kulac, I.; Tezcan, N.; Kim, G.; more...
    Laboratory Investigation (2024)

    Fulltext@MSK | Save
  • Subgrading of G2 pancreatic neuroendocrine tumors as 2A (Ki67 3% to ≤ 10%) versus 2B (10% to ≤ 20%) identifes behaviorally distinct subsets in keeping with the evolving management protocols
    Journal Article

    Eren, O. C.; Bagci, P.; Balci, S.; Ohike, N.; Saka, B.; Sokmensuer, C.; Leblebici, C. B.; Xue, Y.; Reid, M. D.; Krasinskas, A. M.; more...
    Annals of Surgical Oncology (2024)

    Fulltext@MSK | Save
  • ASO Author Reflections: Prognostic value of subgrading G2 pancreatic neuroendocrine tumors as 2A versus 2B
    Editorial

    Eren, O. C.; Bagci, P.; Balci, S.; Ohike, N.; Saka, B.; Sokmensuer, C.; Leblebici, C. B.; Xue, Y.; Reid, M. D.; Krasinskas, A. M.; more...
    Annals of Surgical Oncology (2024)

    Fulltext@MSK | Save
  • Durvalumab and stereotactic ablative body radiotherapy (SABR) in locally advanced (LA) and borderline resectable (BR) pancreatic cancer (PDAC): Long-term outcomes and correlative insights
    Meeting Abstract

    Keane, F.; Tuli, R.; O'Connor, C. A.; Schwartz, C.; Park, W.; Varghese, A. M.; Perry, M.; Singhal, A.; Vardhana, S.; Hendifar, A. E.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Intra-ampullary papillary tubular neoplasm (IAPN): Clinicopathologic analysis of 72 cases highlights the distinctive characteristics of a poorly recognized entity
    Journal Article

    Tarcan, Z. C.; Esmer, R.; Akar, K. E.; Bagci, P.; Bozkurtlar, E.; Saka, B.; Armutlu, A.; Sahin Ozkan, H.; Ozcan, K.; Taskin, O. C.; more...
    American Journal of Surgical Pathology (2024)

    Fulltext@MSK | Save